Amr Saad
Impact in
- Rheumatology top 5%
- Spondyloarthritis Studies and Treatments
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Hematology top 10%
- Autoimmune and Inflammatory Disorders Research
Papers in
-
- Retinal Imaging and Analysis 6
- Corneal surgery and disorders 5
- Retinal and Macular Surgery 2
-
- Retinal Diseases and Treatments 4
- Retinal and Optic Conditions 3
- Co-authors
- Darren M. Ashcroft (4 shared papers)Peter Noyce (3 shared papers)Deborah Symmons (3 shared papers)Kimme L Hyrich (3 shared papers)Kath Watson (2 shared papers)Андреас Фрингс (8 shared papers)Gerd Geerling (1 shared paper)Samar Farid (1 shared paper)
- Journals
- PLoS ONE (3 papers)Investigative Ophthalmology & Visual Science (2 papers)Arthritis Care & Research (1 paper)Scientific Reports (1 paper)Expert Opinion on Drug Safety (1 paper)
- Partner nations
- GermanySwitzerlandHungary
In The Last Decade
Amr Saad
21 papers receiving 364 citations
Peers
Comparison fields: 5 of 52
- Rheumatology 230
- Hematology 61
- Immunology 87
- Toxicology 11
- Radiology, Nuclear Medicine and Imaging 35
Countries citing papers authored by Amr Saad
This map shows the geographic impact of Amr Saad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amr Saad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amr Saad more than expected).
Fields of papers citing papers by Amr Saad
This network shows the impact of papers produced by Amr Saad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amr Saad. The network helps show where Amr Saad may publish in the future.
Co-authors
The 25 scholars most cited alongside Amr Saad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 167 | |
| 2 | Risks and benefits of tumor necrosis factor-alpha inhibitors in the management of psoriatic arthritis: systematic review and metaanalysis of randomized controlled trials. | 2008 | 88 |
| 3 | 2010 | 29 | |
| 4 | 2024 | 14 | |
| 5 | 2023 | 14 | |
| 6 | 2005 | 14 | |
| 7 | 2015 | 13 | |
| 8 | 2023 | 4 | |
| 9 | 2011 | 4 | |
| 10 | 2024 | 3 | |
| 11 | 2023 | 3 | |
| 12 | 2024 | 3 | |
| 13 | 2023 | 2 | |
| 14 | 2024 | 2 | |
| 15 | 2025 | 2 | |
| 16 | 2024 | 2 | |
| 17 | 2024 | 2 | |
| 18 | 2025 | 1 | |
| 19 | 2024 | 1 | |
| 20 | 2025 | 1 |
About Amr Saad
Amr Saad is a scholar working on Radiology, Nuclear Medicine and Imaging, Ophthalmology, Rheumatology, Biomedical Engineering and Molecular Biology, having authored 26 papers that have together received 370 indexed citations. Recurring topics across this work include Retinal Imaging and Analysis (6 papers), Corneal surgery and disorders (5 papers), Retinal Diseases and Treatments (4 papers), Spondyloarthritis Studies and Treatments (4 papers), Retinal and Optic Conditions (3 papers), Retinal and Macular Surgery (2 papers), Ophthalmology and Visual Impairment Studies (1 paper) and Optical Coherence Tomography Applications (1 paper). The work is most often cited by research in Rheumatology (230 citations), Hematology (61 citations), Immunology (87 citations), Toxicology (11 citations) and Radiology, Nuclear Medicine and Imaging (35 citations). Amr Saad has collaborated with scholars based in Germany, Switzerland and Hungary. Frequent co-authors include Darren M. Ashcroft, Peter Noyce, Deborah Symmons, Kimme L Hyrich, Kath Watson, Андреас Фрингс, Gerd Geerling, Samar Farid, Nirmeen A. Sabry and Gábor Márk Somfai. Their work appears in journals such as PLoS ONE, Investigative Ophthalmology & Visual Science, Arthritis Care & Research, Scientific Reports and Expert Opinion on Drug Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.